JACKIE STUCKEY: Open Payments
NPI 1689696627 · FOXWORTH, MS. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$436 in 22 payments from 7 companies in 2025. Trend: 2023 $257 · 2024 $497 · 2025 $436
Food & beverage: $436
| Company | Payments | Amount |
|---|---|---|
| Lilly USA, LLC | 6 | $113 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 5 | $112 |
| AstraZeneca Pharmaceuticals LP | 4 | $81 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 3 | $55 |
| ABBVIE INC. | 2 | $31 |
| Abbott Laboratories | 1 | $25 |
| Medtronic, Inc. | 1 | $18 |
Products named: XIFAXAN, MOUNJARO, CAPLYTA, FARXIGA, BREZTRI, ETERNA, INTELLIS ADAPTIVESTIM, LINZESS.
Industry payments across MS — which companies pay providers there.
